Soon after the discovery of radioactivity it was shown that radionuclides can be used both for diagnostic and therapeutic studies, depending on the characteristic radiations emitted by them. By 1960’s the radionuclide production technology using nuclear reactors was well established. In early 1970’s a renaissance of the cyclotrons occurred because many of the neutron deficient radionuclides could only be produced using irradiations with charged particles, like protons, deuterons, α-particles, etc. Initially, interest was directed towards radioactive gases for inhalation studies and other radionuclides for scintigraphy. Later, with the advent of emission tomography, i.e. Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET), the emphasis shifted to 123I and positron emitters [cf. 1–3], and tremendous progress ensued. In order to keep abreast of the fast developments, a Symposium was organized at the Brookhaven National Laboratory (BNL), USA, in 1976, with the title “Radiopharmaceutical Chemistry”. This became a biennial event, with alternate meetings in North America and Europe. It included all aspects of radionuclide and radiopharmaceutical research. About a decade later, however, it was realized that for discussion of technical aspects, a separate forum would be more appropriate. A group of experts therefore convened the first Targetry Workshop in Heidelberg in 1985. Thereafter it was established as a recurring Workshop, with its scope enlargened to include also nuclear and radiochemical problems. Today, the major conference on Radiopharmaceutical Sciences and the specialist International Workshop on Target-ry and Target Chemistry are held in alternate years. The present Workshop is No. 15 in the series and it is being jointly held by the research groups in Dresden and Prague, both of which have a long tradition of cyclotron production of radionuclides. In this talk, some personal reminiscences and impressions of the historical de-velopments in the field over the last 40 years will be briefly described.

Soon after the discovery of radioactivity it was shown that radionuclides can be used both for diagnostic and therapeutic studies, depending on the characteristic radiations emitted by them. By 1960’s the radionuclide production technology using nuclear reactors was well established. In early 1970’s a renaissance of the cyclotrons occurred because many of the neutron deficient radionuclides could only be produced using irradiations with charged particles, like protons, deuterons, α-particles, etc. Initially, interest was directed towards radioactive gases for inhalation studies and other radionuclides for scintigraphy. Later, with the advent of emission tomography, i.e. Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET), the emphasis shifted to 123I and positron emitters [cf. 1–3], and tremendous progress ensued. In order to keep abreast of the fast developments, a Symposium was organized at the Brookhaven National Laboratory (BNL), USA, in 1976, with the title “Radiopharmaceutical Chemistry”. This became a biennial event, with alternate meetings in North America and Europe. It included all aspects of radionuclide and radiopharmaceutical research. About a decade later, however, it was realized that for discussion of technical aspects, a separate forum would be more appropriate. A group of experts therefore convened the first Targetry Workshop in Heidelberg in 1985. Thereafter it was established as a recurring Workshop, with its scope enlargened to include also nuclear and radiochemical problems. Today, the major conference on Radiopharmaceutical Sciences and the specialist International Workshop on Target-ry and Target Chemistry are held in alternate years. The present Workshop is No. 15 in the series and it is being jointly held by the research groups in Dresden and Prague, both of which have a long tradition of cyclotron production of radionuclides. In this talk, some personal reminiscences and impressions of the historical de-velopments in the field over the last 40 years will be briefly described.